Log In
BCIQ
Print this Print this
 

ARM210, S48168

  Manage Alerts
Collapse Summary General Information
Company Armgo Pharma Inc.
DescriptionSmall molecule Rycal that repairs calcium leaks through the ryanodine receptor 1 (RyR1)
Molecular Target Ryanodine receptor 1 (RyR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMuscular dystrophy
Indication DetailsTreat Duchenne muscular dystrophy (DMD)
Regulatory Designation U.S. - Orphan Drug (Treat Duchenne muscular dystrophy (DMD));
U.S. - Rare Pediatric Disease (Treat Duchenne muscular dystrophy (DMD))
PartnerServier

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today